Literature DB >> 7296356

Senile cataracts: evidence for acceleration by diabetes and deceleration by salicylate.

E Cotlier.   

Abstract

A method is described for determining the natural progression of senile cataracts in humans and whether certain factors accelerate or decelerate this progression. The method consists in plotting the age of the patient against the degree of opacity of the cataract to find the regression relation. A comparison of cataracts from diabetic and nondiabetic patients revealed that diabetes accelerated senile cataract formation, so that there was a difference of 9.6 years in the age of the two groups with more dense cataracts. Plasma tryptophan levels, which are increased in cataract patients, are lowered by acetylsalicylic acid (ASA). In this study ASA decelerated cataract formation in diabetic and nondiabetic patients. Among the nondiabetic patients cataract formation in a group with osteoarthritis was delayed by an average of 10 years. Deceleration of cataract formation resulting from ASA administration may reduce the need for surgical removal of cataracts.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296356

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  13 in total

Review 1.  Methods for evaluation of lens changes.

Authors:  N A Brown; A J Bron; J M Sparrow
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

2.  Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5.

Authors: 
Journal:  Ophthalmology       Date:  2001-08       Impact factor: 12.079

3.  Changes of the thiol levels in the corneas of the diabetic rats: effect of carnosine, aspirin and a combination eye drops.

Authors:  Qiong Shi; Hong Yan
Journal:  Int J Ophthalmol       Date:  2010-09-18       Impact factor: 1.779

Review 4.  Can drugs or micronutrients prevent cataract?

Authors:  J J Harding
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Aspirin use and chronic diseases: a cohort study of the elderly.

Authors:  A Paganini-Hill; A Chao; R K Ross; B E Henderson
Journal:  BMJ       Date:  1989-11-18

6.  The Oxford Clinical Cataract Classification and Grading System.

Authors:  J M Sparrow; A J Bron; N A Brown; W Ayliffe; A R Hill
Journal:  Int Ophthalmol       Date:  1986-12       Impact factor: 2.031

7.  The transparency of the lens: a comparison between diabetic and non-diabetic patients.

Authors:  S L Franklin; J Flammer; R De Natale; C Rutishuser
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

8.  Aspirin effect on cataract formation in patients with rheumatoid arthritis alone or combined with diabetes.

Authors:  E Cotlier
Journal:  Int Ophthalmol       Date:  1981-05       Impact factor: 2.031

9.  Does aspirin affect the rate of cataract formation? Cross-sectional results during a randomised double-blind placebo controlled trial to prevent serious vascular events. UK-TIA Study Group.

Authors: 
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

10.  Effect of a combination of carnosine and aspirin eye drops on streptozotocin -- induced diabetic cataract in rats.

Authors:  Qiong Shi; Hong Yan; Ming-Yong Li; John J Harding
Journal:  Mol Vis       Date:  2009-10-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.